NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
- Conditions
- AtherosclerosisCoronary Artery Disease
- Interventions
- Device: Percutaneous coronary intervention (NG PROMUS)
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01703000
- Locations
- 🇦🇺
Fremantle Hospital, Fremantle, Western Australia, Australia
🇳🇿Mercy Angiography Unit, Ltd. Mercy Hospital, Auckland, New Zealand
🇳🇿Auckland City Hospital, Auckland, New Zealand
WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture
- Conditions
- Refractory Anastomotic Esophageal Strictures
- Interventions
- Device: WallFlex Esophageal RX Fully Covered StentDevice: Esophageal Bougie Dilator Per Investigator preference
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT01699542
- Locations
- 🇧🇷
Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil
🇳🇱Erasmus Medical Center, Rotterdam, CE, Netherlands
🇳🇱Academisch Medisch Centrum, Amsterdam, Netherlands
Safety and Performance Study of the INGEVITY Lead
- Conditions
- BradycardiaSinus Node Dysfunction
- Interventions
- Device: INGEVITY lead
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2020-03-10
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1060
- Registration Number
- NCT01688843
- Locations
- 🇺🇸
Mercy Gilbert Medical Center, Gilbert, Arizona, United States
🇺🇸Cardiovascular Consultants, LTD, Glendale, Arizona, United States
🇺🇸Pima Heart Physicians, PC, Tucson, Arizona, United States
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
- Conditions
- Paroxysmal Atrial Fibrillation (PAF)
- Interventions
- Device: Blazer Open-Irrigated Ablation Catheter (Boston Scientific)Device: FDA Approved Open-Irrigated Ablation Catheter
- First Posted Date
- 2012-09-18
- Last Posted Date
- 2018-11-21
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 398
- Registration Number
- NCT01687166
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Hunstville Hospital, Huntsville, Alabama, United States
🇺🇸Sequoia Hospital, Redwood City, California, United States
Post-Approval Study of PROMUS Element™ in China
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 2016
- Registration Number
- NCT01677585
- Locations
- 🇨🇳
Second Affliated Hosptial Zhejiang University College of Medicine, Hangzhou, China
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
- Conditions
- Uterine Fibroids
- Interventions
- Device: Embosphere®Device: Embozene® Microspheres
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 4
- Registration Number
- NCT01675011
- Locations
- 🇺🇸
Albany Medical Center, Albany, New York, United States
🇺🇸North Shore LIJ Medical Center, New Hyde Park, New York, United States
Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain
- Conditions
- Chronic Pain
- Interventions
- Device: Neurostimulation device implantation
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01665040
- Locations
- 🇦🇺
Metro Spinal Clinic, Caulfield, Australia
🇦🇺Hunter Clinical Research, Melbourne, Australia
🇧🇪AZ Delta, Roeselare, Belgium
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PROMUS Element PlusDevice: SYNERGY
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1684
- Registration Number
- NCT01665053
- Locations
- 🇺🇸
Baptist Medical Center - Princeton, Birmingham, Alabama, United States
🇺🇸Banner Good Samaritan Medical Center, Phoenix, Arizona, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector
- Conditions
- Chronic Pain
- Interventions
- Device: BSC approved SCS Trial Therapy w/ OMGDevice: Non Boston Scientific SCS Trial Therapy
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 27
- Registration Number
- NCT01643213
- Locations
- 🇺🇸
Hope Research Institute, Phoenix, Arizona, United States
🇺🇸Neurovations, Napa, California, United States
🇺🇸Comprehensive Pain Specialists, Broomfield, Colorado, United States
Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter
- Conditions
- Cardiac Arrhythmias
- Interventions
- Device: Rhythmia Mapping System and the Rhythmia Mapping Catheter
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 7
- Registration Number
- NCT01642537
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada